Efficient marmoset genome engineering by autologous embryo transfer and CRISPR/Cas9 technology.

Sci Rep

Section of Animal Research and Laboratory of Animal Resources, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.

Published: October 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Genetic engineering of non-human primates, which are most closely related to humans, has been expected to generate ideal animal models for human genetic diseases. The common marmoset (Callithrix jacchus) is a non-human primate species adequate for the production of genetically modified animals because of their small body size and high reproductive capacity. Autologous embryo transfer (AET) is routinely utilized in assisted reproductive technologies for humans but not for experimental animals. This study has developed a novel method for efficiently producing mutant marmosets using AET and CRISPR/Cas9 systems. The embryos were recovered from oviducts of naturally mated females, injected with Cas9/guide RNA, and transferred into the oviducts of the donors. This AET method can reduce the time for in vitro culture of embryos to less than 30 min. This method uses an embryo donor as the recipient, thus reducing the number of animals and allowing for "Reduction" in the 3R principles of humane experimental technique. Furthermore, this method can utilize nulliparous females as well as parous females. We applied our novel method and generated the 6 marmosets carrying mutations in the fragile X mental retardation 1 (FMR1) gene using only 18 females including 14 nulliparous females.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511084PMC
http://dx.doi.org/10.1038/s41598-021-99656-4DOI Listing

Publication Analysis

Top Keywords

autologous embryo
8
embryo transfer
8
novel method
8
nulliparous females
8
method
5
females
5
efficient marmoset
4
marmoset genome
4
genome engineering
4
engineering autologous
4

Similar Publications

Background: In 2012, oocyte cryopreservation was no longer deemed experimental by the American Society of Reproductive Medicine. Since then, awareness and utilization of planned oocyte cryopreservation has become much more widespread. However, little is known regarding current national trends and the rate of warming and utilization of cryopreserved oocytes.

View Article and Find Full Text PDF

Impact of hormone replacement therapy on serum thyroid-stimulating hormone: a retrospective analysis.

Reprod Biomed Online

May 2025

IVIRMA Global Research Alliance, IVI Roma, Rome, Italy.; IVIRMA Global Research Alliance, IVI Foundation-IIS la Fe, Valencia, Spain.. Electronic address:

Research Question: What is the impact of hormone replacement therapy (HRT) on serum thyroid-stimulating hormone (TSH) during endometrial preparation for single-embryo transfer (SET)?

Design: This retrospective cohort study included 516 women (≤49 years) who underwent SET with either autologous or donor oocytes, between January 2022 and January 2023 at IVI Rome. TSH was measured at baseline (T), during endometrial thickness assessment (T), on embryo transfer day (T), and at the pregnancy test (T). TSH >2.

View Article and Find Full Text PDF

Isolation and characterization of mesenchymal stromal cells derived from equine ovarian follicular aspirates.

Theriogenology

August 2025

Departamento de Medicina Animal, Grupo de Investigación Medicina Interna Veterinaria (MINVET), Instituto Universitario de Investigación INBIO G+C, Facultad de Veterinaria, Universidad de Extremadura, Av. de la Universidad s/n, 10004, Cáceres, Spain. Electronic address:

The use of mesenchymal stromal cells (MSCs) in equine reproduction is increasing its interest in the treatment of specific pathologies. MSCs have been isolated from follicular aspirates obtained during transvaginal oocyte aspiration in women, offering a novel source for autologous therapies in reproductive treatments. However, this approach has not been tested in mares despite the common use of transvaginal oocyte aspiration for oocyte collection to produce equine embryos in vitro.

View Article and Find Full Text PDF

Objective: To analyze the effect of autologous platelet-rich plasma (PRP) intrauterine perfusion on the clinical outcomes of frozen-thawed embryo transfer in patients with chronic endometritis.

Methods: A retrospective continuous cohort of 219 patients diagnosed with chronic endometritis at the Reproductive Medicine Center of Affiliated Hospital of Putian University between January 2020 and December 2022, undergoing their first frozen-thawed embryo transfer cycle, was included. All patients received standardized oral doxycycline treatment after diagnosis.

View Article and Find Full Text PDF

Comparative Age-Stratified Analysis of Live-Birth Outcomes in Primary Embryo Transfer to Assess the Effect of Preimplantation Genetic Testing for Aneuploidy.

Obstet Gynecol

August 2025

Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut.

Objective: To investigate whether the perceived advantages of preimplantation genetic testing for aneuploidy (PGT-A) are attributable to genetic testing itself or to transferring a thawed frozen embryo into a receptive endometrium. We compared live-birth and cumulative live-birth outcomes across three groups: primary frozen embryo transfer (FET) with PGT-A, FET without PGT-A, and fresh transfers in initial autologous assisted reproductive technology (ART) cycles.

Methods: We performed a retrospective analysis from the 2014-2020 Society for Assisted Reproductive Technology Clinic Outcome Reporting System database, comparing success rates of primary FET with PGT-A, FET without PGT-A, and fresh transfers.

View Article and Find Full Text PDF